Pédiatrie Tumeurs solides
INFORM2 - NIVENT (IC 2018-07)
INFORM2 Exploratory Multinational Phase I/II Combination Study of Nivolumab and Entinostat in Children and Adolescents With Refractory High-risk Malignancies
Paris
GUDRUN SCHLEIERMACHER